Work

Abstract 3096: Development of pyrrolopyrimidine-based ACK1 inhibitors for cancer therapeutics

Year: 2023

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2023-3096

Authors: Angelie Matar, Yuliya Marusyk, Sujeewa Ranatunga, Tegan Rowsell, Narmin Amin, Hannah Walker, Timothy Tran, Kathy Yang, Derek Duckett, Gary Reuther, Harshani Lawrence, Nicholas Lawrence

Institution: Moffitt Cancer Center

Language: English

Topic: Heterocyclic Compound Synthesis and Bioactivity

Subfield: Organic Chemistry

Field: Chemistry

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4379983562

Cites:

Cited by:

Related to: 10